The natural course of asymptomatic Chlamydia trachomatis infections: 45% Clearance and no development of clinical PID after one-year follow-up

International Journal of STD and AIDS

Volumn 13, Issue SUPPL. 2, 2002, Pages 12-18

  Morré, Servaas A ^a   Van den Brule, Adriaan J C ^a   Rozendaal, Lawrence ^a   Boeke, A Joan P ^b   Voorhorst, Feja J ^a   De Blok, Sjoerd ^c   Meijer, Chris J L M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

Asymptomatic infection; C. trachomatis; Pelvic inflammatory disease

Indexed keywords

BACTERIAL DNA;

ADULT; ANTIBIOTIC THERAPY; CALCULATION; CASE CONTROL STUDY; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; DEMOGRAPHY; DISEASE COURSE; DNA ISOLATION; DRUG SPECIFICITY; FEMALE; FOLLOW UP; HUMAN; JOB ANALYSIS; MAJOR CLINICAL STUDY; NETHERLANDS; PELVIC INFLAMMATORY DISEASE; PREVALENCE; PRIORITY JOURNAL; SCREENING; SELF REPORT; SEROTYPE; SEXUAL BEHAVIOR; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0036894969     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/095646202762226092     Document Type: Conference Paper

References (32)

1. Paavonen J, Puolakkainen M, Paukku M, Sintonen H. Cost-benefit analysis of first-void urine Chlamydia trachomatis screening program. Obstet Gynecol 1998;92:292-8
2. Weström L, Joesoef R, Reynolds G, Hadgu A, Tompson SE. Pelvic inflammatory disease and fertility. A cohort study of 1844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 1992;19:185-92
3. Hillis SD, Owens LM, Marchbanks PA, Amsterdam LE, MacKenzie WR. Recurrent chlamydial infections increase the risk of hospitalization for ectopic pregnancy and pelvic inflammatory disease. Am J Obstet Gynecol 1997;1:103-6
4. Golden MR, Schillinger JA, Markowitz L, St Louis ME. Duration of untreated genital infections with Chlamydia trachomatis. A review of the literature. Sex Transm Dis 2000;27:329-37
5. McCormack WM, Alpert S, McComb DE, Nichols RL, Semine DZ, Zinner SH. Fifteen-month follow-up study of women infected with Chlamydia trachomatis. N Engl J Med 1979;300:123-5
6. Rahm VA, Velsheim J, Gleerup A, Gnarpe H, Rosen G. Asymptomatic carriage of Chlamydia trachomatis: A study of 109 teenage girls. Eur J Sex Transm Dis 1986;3:91-4
7. Crotchfelt KA, Pare B, Gaydos C, Quinn TC. Detection of Chlamydia trachomatis by the gen-probe Amplified Chlamydia trachomatis Assay (AMP CT) in urine specimens from men and women and endocervical specimens from women. J Clin Microbiol 1998;36:391-4
8. Ferrero DV, Meyers HN, Schultz DE, Willis SA. Performance of the gen-probe Amplified Chlamydia trachomatis assay in detecting Chlamydia trachomatis in endocervical and urine specimens from women and men and urethral and urine specimens from men attending sexually transmitted disease and family planning clinics. J Clin Microbiol 1998;36:3230-3
9. Gaydos CA, Howell MR, Quinn TC, Gaydos JC, McKee Jr KT. Use of ligase chain reaction with urine versus cervical culture for detection of Chlamydia trachomatis in an asymptomatic military population of pregnant and non-pregnant females attending papanicolaou smear clinics. J Clin Microbiol 1998;36:1300-4
10. Lee HH, Chernesky MA, Schachter J, et al. Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine. Lancet 1999;345:213-16
11. Morré SA, van Valkengoed IGM, de Jong A, et al. Mailed, home-obtained urine specimens: A reliable screening approach for detecting asymptomatic Chlamydia trachomatis infections. J Clin Microbiol 1999;37:976-80
12. Morré SA, Sillekens P, Jacobs MV, et al. Monitoring of Chlamydia trachomatis infections after antibiotic treatment using RNA amplification by NASBA. J Clin Pathol Mol Pathol 1998;51:149-54
13. Morré SA, Sillekens P, Jacobs MW, et al. RNA amplification by NASBA with an internal standard enables reliable detection of Chlamydia trachomatis in cervical scrapings and urine samples. J Clin Microbiol 1996;34:3108-14
14. Morré SA, Moes RM, van Valkengoed IGM, et al. Genotyping of Chlamydia trachomatis in urine specimen will facilitate large epidemiological studies. J Clin Microbiol 1998;36:3077-8
15. Lan J, Ossewaarde JM, Walboomers JMM, Meijer CJLM, van den Brule AJC. Improved PCR sensitivity for direct genotyping of Chlamydia trachomatis serovars by using a nested PCR. J Clin Microbiol 1994;32:528-30
16. Morré SA, Ossewaarde JM, Lan J, et al. Serotyping and genotyping of genital Chlamydia trachomatis isolates reveal variants of serovar Ba, G and J as confirmed by Omp1 nucleotide sequence analysis. J Clin Microbiol 1998;36:345-51
17. Schlesselman JJ. Basic concepts in the assessment of risk. In: Schlesselmann JJ, Stolley PD, eds. Case-control Studies. Design, Conduct, Analysis. New York: Oxford University Press, 1982:27-31
18. Østergaard L, Lundemose AG, Birkelund S, Christiansen G. Age and sex correlation of Chlamydia trachomatis infections evaluated by the culture technique and by an enzyme immunosorbent assay, IDEIA. Eur J Obstet Gynecol Reprod Biol 1990;34:273-81
19. Weström L. Incidence, prevalence and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol 1980;138:880-92
20. Munk C, Morré SA, Krüger-Kjaer S, Bock JE, Meijer CJLM, van den Brule AJC. PCR-detected Chlamydia trachomatis infections from the uterine cervix of young women from the general populations. Sex Transm Dis 1999;26:325-8
21. Ito JI, Lyons JM, Airo-Brown LP. Variation in virulence among oculogenital serovars of Chlamydia trachomatis in experimental genital tract infection. Infect Immun 1990;58:2021-3
22. Landers DV, Erlich K, Sung M, Schachter J. Role of L3T4-bearing T-cell populations in experimental murine chlamydial salpingitis. Infect Immun 1991;59:3774-7
23. Perry LL, Feilzer K, Caldwell HD. Neither interleukin-6 nor inducible nitric oxide synthase required for clearance of Chlamydia trachomatis from murine genital tract epithelium. Infect Immun 1998;66:12656-9
24. Ramsey KH, Rank RG. Resolution of Chlamydial genital infections with antigen-specific T-lymphocyte lines. Infect Immun 1991;59:925-31
25. Yang X, HayGlass KT, Brunham RC. Genetically determined differences in IL-10 and IFN-gamma responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection. J Immunol 1996;156:4338-44
26. Kaushic C, Murdin AD, Underdown BJ, Wira CR. Chlamydia trachomatis infection in the female reproductive tract of the rat: Influence of progesterone on infectivity and immune responses. Infect Immun 1998;66:893-8
27. Rank RG, White HJ, Barron AL. Humoral immunity in the resolution of genital infections in female guinea pigs infected with the agent of guinea pig inclusion conjunctivitis. Infect Immun 1979;26:573-9
28. Morré SA, Rozendaal L, van Valkengoed IGM, et al. Urogenital Chlamydia trachomatis serovars in men and women having either a symptomatic or an asymptomatic infection: An association with clinical manifestations? J Clin Microbiol 2000;38:2292-6
29. Van de Laar MJW, Lan J, van Duynhoven YTHP, et al. Differences in clinical manifestations of genital chlamydial infections related to serovars. Genitourin Med 1996;72:261-5
30. Van Duynhoven YTHP, Ossewaarde JM, Derksen-Nawrocki RP, van der Meijden WI, van de Laar MJW. Chlamydia trachomatis genotypes; correlation with clinical manifestations and patients' characteristics. Clin Infect Dis 1998;26:314-22
31. Weström L, Mårdh P-A. Chlamydial salpingitis. Br Med Bull 1983;39:145-50
32. Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical Chlamydial infections. N Engl J Med 1996;334:1362-6